RedHill Biopharma reported $1.3M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cara Therapeutics USD 366M 338M Sep/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Cronos Group USD 958.02M 45.05M Mar/2026
RedHill Biopharma USD 1000K 4M Jun/2026